Yes. Since the regulators have a new standard, getting it right would be paramount, and although reef-rad points out it applies to current tests/scan requirements, going back to look at which tests/scans were primarily used throughout the trial the might be important. Remember, the regulators requested the docs. I'd certainly want to know how that might affect MRI readings during an ongoing trial if I was in their position. Particularly with new patients, because it became a standard method to diagnose response/recurrence during that time frame.
News 
Market Data 
Discover 
